Company Category: Sepsis

The Korean Academy of Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (KATRD) represents health professionals and scientific societies related to respiratory disease in South Korea. KATRD endeavors to promote research, patient care, and education in the field of respiratory disease and to improve the health of patients with respiratory diseases in South Korea. Founded in 1953, KATRD has the 66 years of history. Since 1962, the society has held more than 120 academic conferences and 1,656 membership.

Read More

Springer Nature

Springer Nature is a leading global scientific, technical and medical portfolio, providing researchers with quality content through innovative products and services from trusted brands like Springer, Nature Portfolio, and BMC. Springer Nature has one of the strongest STM and HSS eBook collections and a comprehensive range of hybrid and open access journals. Visit our booth to learn about the benefits of publishing with us and to browse our latest titles on display. | Springer Nature advances discovery by serving the whole research community. All the research we publish is robust and in the best possible format to be discovered, accessed, used, re-used and shared. Springer Nature is home to brands including [Springer, Nature Research, BMC, Palgrave Macmillan and Scientific American]. Please visit our booth to learn about publishing with us. | Springer Nature is a leading global research, educational and professional publisher, home to an array of trusted brands, including Springer, Nature Portfolio, Palgrave Macmillan, BioMed Central, and Scientific American. We provide quality content for the Genetics community through innovative products and services, extensive eBook collections, and hybrid/open access journals across the sciences and humanities. Meet with our editors to learn about the benefits of publishing with us. Find out more: www.springernature.com | Springer Nature advances discovery by serving the whole research community. All the research we publish is robust and in the best possible format to be discovered, accessed, used, re-used and shared. Springer Nature is home to brands including [Springer, Nature Research, BMC, Palgrave Macmillan and Scientific American]. Please visit springernature.com and @SpringerNature. | Springer Nature is one of the world’s leading global research, educational and professional publishers, home to an array of respected and trusted brands providing quality content through a range of innovative products and services. Springer Nature advances discovery by publishing trusted research, supporting the development of new ideas and championing open science. We are committed to playing our part in accelerating solutions to address the world’s urgent challenges. The newest addition to the Springer Nature family of products is protocols.io, a secure platform for developing, optimizing, sharing, and running reproducible research methods. | Springer Nature Information and insights to drive research, development and excellence Fuel your innovation pipeline and improve commercial outcomes with Springer Nature’s comprehensive portfolio of content and solutions. With over 150 years of expertise in scientific publishing, we are a trusted partner to life sciences organizations, providing the insights, data and platforms needed to accelerate research, enhance decision-making, and drive business success. Our solutions empower biopharma and biotech professionals to stay ahead in a rapidly evolving industry: AdisInsight Make confident decisions in drug development In the fast-paced world of biopharma, every decision counts. AdisInsight provides trusted, expertly curated intelligence on drug development, clinical trials, deals and safety, empowering you to act with certainty. Stay Ahead: Updated daily with the latest drug and trial data. Trust Your Data: Expert-validated insights with full transparency on sources. Seamless Integration: Plug directly into your internal analytics for deeper insights. Strategic Advantage: Identify opportunities, track competitors and accelerate decision-making. Navigate drug development with confidence with AdisInsight. adisinsight.springer.com Biopharma Dealmakers Make biopharma connections today Biopharma Dealmakers is the premier platform connecting life sciences innovators, investors and pharma leaders. Get exclusive deal insights, funding trends and opportunities to showcase your company. Trusted Industry Insights: Editorial coverage on M&A, licensing, and funding. Global Reach: Distributed with Nature Biotechnology and Nature Reviews Drug Discovery. Partnering Opportunities: Feature your company’s assets, innovations and investment needs. Branded Content: Tailored campaigns to position your company in front of the right audience. Connect, partner and accelerate your next deal with Biopharma Dealmakers. nature.com/biopharmdeal protocols.io Accelerate innovation with reproducible research protocols.io is a secure, interactive platform for developing and sharing research methods, ensuring standardization, collaboration, and compliance. Reproducibility First: Step-by-step protocols with version tracking. Seamless Collaboration: Share, comment, and refine methods in real time. Compliance-Ready: Supports HIPAA and 21 CFR Part 11 compliance. Institutional Knowledge: Preserve protocols and expertise within your organization. Streamline research and ensure reproducibility with protocols.io. protocols.io Nature Portfolio Engage the STEM community with impact Reach a global community of scientists, healthcare professionals and decision-makers with Nature Portfolio’s advertising and content solutions. Unmatched Reach: 55M monthly users, 6.5M newsletter subscribers, 100K podcast listeners. Precision Targeting: Data-driven campaigns for maximum engagement. Multi-Channel Advertising: Digital, print, email and podcast options. Branded Content: Award-winning storytelling aligned with Nature’s trusted voice. Align your brand with scientific excellence—partner with Nature Portfolio. partnerships.nature.com Text and Data Mining (TDM) With the ever-expanding volume of valuable information becoming available daily, any fragment of it could hold the key to the next breakthrough. By analysing this information, and uncovering patterns and trends, you can get the insights you need to fast-track innovation. By choosing Springer Nature’s API as your data source, you’ll have access to our extensive collection of high-quality groundbreaking research, across all subject areas. All of our data is from a trusted, peer-reviewed content source, giving you information you can trust and ultimately leading to higher quality output. You can apply our data to meet a limitless range of business goals, from understanding trending topics to finding potential collaborators to building new products. Data Solutions (TDM) | Springer Nature is a leading global scientific, technical and medical publisher, providing researchers with innovative information, products and services. | Springer is a leading global research publisher, providing researchers with quality Radiology content through innovative information, products and services. As part of Springer Nature, Springer sits alongside other trusted brands like Nature Portfolio and BMC to provide a comprehensive range of books, eBook collections, and hybrid/open access journals. Visit our booth to learn about the benefits of publishing with us and to browse our latest titles on display.

Read More

Prenosis

Prenosis is a biology-based technology company redefining the standard of care for critical conditions. We believe healthcare should not follow a one-size-fits-all model. Instead, our mission is to tailor healthcare to each patient’s biology through the creation and delivery of integrated diagnostics and therapeutics. We use deep data and AI to build tools that augment clinical diagnosis of critical conditions based on each patient’s unique biological profile. Unlike other AI-driven diagnostics, we go further by developing therapies that help providers deliver personalized care. Our Immunix™ platform powers the development of a variety of AI-based diagnostics, including Sepsis ImmunoScore®, the first FDA-authorized AI diagnostic tool for sepsis. At Prenosis, we see people differently. For more information, visit us at prenosis.com or find us on LinkedIn.

Read More

Praxis Medical LLC

Praxis Medical is committed to developing innovative technologies that address unmet clinical needs to improve the lives of doctors, providers, and most importantly, patients. We are developing EndoCore- the world’s first motorized EBUS fine needle biopsy device. The EndoCore is designed to rotate the EBUS needle at the time of biopsy to harvest more cellular material in fewer passes. *This device is investigational.

Read More

PAREXEL

Parexel is a leading global clinical development partner providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 22,000+ global employees work in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind — broadening access and making clinical research a care option for anyone, anywhere. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’s most complex areas while harnessing innovation to drive efficiencies across every phase of the clinical development process. Our insights-driven approach, proven delivery and trusted execution are accelerating the delivery of life-changing treatments to patients — With Heart.™ | Parexel is among the world’s largest CROs, providing full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, we collaborate with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials for patients. We work With HeartTM every day to treat patients with dignity and learn from their experiences, so every trial makes a difference.

Read More

Pan African Thoracic Society (PATS)

A respiratory society made up of healthcare professionals from across the Africa and beyond.

Read More

American College of Chest Physicians (CHEST)

CHEST is a global community of medical leaders dedicated to advancing best patient outcomes through education, clinical research, and team-based care. Since 1935, the journal CHEST® has led the way in pulmonary research and is the most-read journal by respiratory care clinicians. While at the conference, visit booth 1158 to learn more about the expanded CHEST journal family—CHEST® Critical Care and CHEST® Pulmonary—and how to submit your research to our latest open-access journals.

Read More